The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.

In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is "highly effective" and "considered to be of major public health interest." Once the regulator's guidance is accepted by the European Commission, the authorization is valid in all 27 EU member countries as well as Iceland, Norway and Liechtenstein.

Two university hospitals are pioneering new ways to expand lifesaving heart transplants for adults and babies — advances that could help recover would-be heart donations that too often go unused.

The new research aims to overcome barriers for using organs from someone who dies when their heart stops. Called DCD, or donation after circulatory death, it involves a controversial recovery technique or the use of expensive machines.

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest levels seen in more than three decades, and provided life-saving medicines for some of the world's most vulnerable.

But in the last six months, the sudden withdrawal of U.S. money has caused a "systemic shock," U.N. officials warned, adding that if the funding isn't replaced, it could lead to more than 4 million AIDS-related deaths and 6 million more HIV infections by 2029.

More than 14 million of the world's most vulnerable people, a third of them small children, could die by 2030 because of the Trump administration's dismantling of U.S. foreign aid, research projected on Tuesday.

When Armando Ernesto Chau straps on the futuristic smart glasses that a young Mozambican robotics student is developing in the family dining room, he has a vision of a life less confined to his modest home.

Brigitte Bardot lounged barefoot on a Saint-Tropez beach, drawing languorous puffs from her cigarette. Another actor, Jean-Paul Belmondo, swaggered down the Champs-Élysées with smoke curling from his defiant lips, capturing a generation's restless rebellion.

In France, cigarettes were never just cigarettes — they were cinematic statements, flirtations and rebellions wrapped in rolling paper.

France's lower house of parliament, the National Assembly, is voting Tuesday on a bill to allow adults with incurable illness to take lethal medication, as public demands grow across Europe for legal end-of-life options.

Tuesday's vote, expected in the late afternoon, is a key legislative step on the contentious and long-debated issue. If approved by a majority of lawmakers, the bill will be sent to the Senate for further debate.

The U.S. saw a small increase in measles cases this week, an indicator that outbreaks are slowing down, though exposures at a busy airport in Colorado and a Shakira concert in New Jersey are keeping public health experts on their toes.

The Centers for Disease Control and Prevention said Friday that there are 1,046 confirmed measles cases, up 22 from last week. Texas, where the nation's biggest outbreak raged during the late winter and spring, confirmed only 10 more cases this past week for a total of 728.

As the UK Emergency Medical Team (UK-EMT) ends their 5-month deployment in Lebanon, the British Embassy held a workshop for local and international partners.

During a signing ceremony Wednesday for the Laken Riley Act, President Donald Trump claimed that his administration had "identified and stopped $50 million being sent to Gaza to buy condoms for Hamas."

Karoline Leavitt, the White House press secretary, made a similar claim on Tuesday during her debut press briefing, stating that the Department of Government Efficiency and the Office of Management and Budget "found that there was about to be 50 million taxpayer dollars that went out the door to fund condoms in Gaza." She called the alleged aid "a preposterous waste of taxpayer money." But there's no credible evidence to support these claims.